In order to use RunSignup, your browser must accept cookies. Otherwise, you will not be able to register for races or use other functionality of the website. However, your browser doesn't appear to allow cookies by default.
If you still see this message after clicking the link, then your browser settings are likely set to not allow cookies. Please try enabling cookies. You can find instructions at https://www.whatismybrowser.com/guides/how-to-enable-cookies/auto.
Our passionate online fundraisers raise more than $50,000 each year, and have played a huge role over the years, building the culture of the event and helping us raise over $2 million.
There is no minimum fundraising amount and every dollar donated goes directly to The Angel Fund for ALS Research (Angel Fund, Inc.) is an independent non-profit charity (04-3478977) dedicated to supporting ALS (Lou Gehrig’s Disease) investigations at UMass Chan Medical School in Worcester, MA, internationally recognized for its ground-breaking work in the fight against this devastating illness.
*Incentives will be based on funds raised by 12:00 EST on Race Day, 6/17/2023.
How to become a fundraiser:
5k Participants: click here to register and follow the steps to become a fundraiser or create/join a team!.
Volunteers or other supporters: you can still fundraise! Click here to set up your fundraising page or create/join a team!
*Please note that our event does not have running teams. Teams are only for the purpose of linking individual fundraisers together to create a group (“team”).
If you have any questions, please email us at firstname.lastname@example.org. We are happy to help!
Click here to learn more about the research at UMASS Chan Medical School.
MYKAYLA TIMLIN is Running Boston!
Please support our Boston Marathon runner, Mike & Dawn Timlin's daughter Mykayla, who is dedicating her run to raising critical funds for The Angel Fund. She is running in honor of her grandmother, Sharon Timlin. See her profile and make a donation here.
Thank you! Your message was posted to Facebook.